Cargando…
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is mounting evidence that commensal gut microbiota is essential for effective colon cancer treatment, the detailed...
Autores principales: | Ghosh, Sweta, Singh, Rajbir, Vanwinkle, Zachary Matthew, Guo, Haixun, Vemula, Praveen Kumar, Goel, Ajay, Haribabu, Bodduluri, Jala, Venkatakrishna Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330515/ https://www.ncbi.nlm.nih.gov/pubmed/35910798 http://dx.doi.org/10.7150/thno.70754 |
Ejemplares similares
-
Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
por: Singh, Rajbir, et al.
Publicado: (2020) -
Regulation of Intestinal Barrier Function by Microbial Metabolites
por: Ghosh, Sweta, et al.
Publicado: (2021) -
Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis
por: Ghosh, Sweta, et al.
Publicado: (2022) -
Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases
por: Saha, Piu, et al.
Publicado: (2016) -
Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
por: Jala, Venkatakrishna Rao, et al.
Publicado: (2012)